• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Breast density influences tumor subtypes and tumor aggressiveness.

作者信息

Kerlikowske Karla, Phipps Amanda I

出版信息

J Natl Cancer Inst. 2011 Aug 3;103(15):1143-5. doi: 10.1093/jnci/djr263. Epub 2011 Jul 27.

DOI:10.1093/jnci/djr263
PMID:21795663
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3149045/
Abstract
摘要

相似文献

1
Breast density influences tumor subtypes and tumor aggressiveness.乳腺密度会影响肿瘤亚型和肿瘤侵袭性。
J Natl Cancer Inst. 2011 Aug 3;103(15):1143-5. doi: 10.1093/jnci/djr263. Epub 2011 Jul 27.
2
Mammographic breast density and subsequent risk of breast cancer in postmenopausal women according to tumor characteristics.根据肿瘤特征，绝经后妇女的乳腺 X 线摄影密度与乳腺癌后续风险。
J Natl Cancer Inst. 2011 Aug 3;103(15):1179-89. doi: 10.1093/jnci/djr225. Epub 2011 Jul 27.
3
Prognostic Factors on the Positivity for Metastases of the Axillary Lymph Nodes from Primary Breast Cancer.原发性乳腺癌腋窝淋巴结转移阳性的预后因素
Pril (Makedon Akad Nauk Umet Odd Med Nauki). 2017 Mar 1;38(1):81-90. doi: 10.1515/prilozi-2017-0011.
4
Absent progesterone receptor expression in the lymph node metastases of ER-positive, HER2-negative breast cancer is associated with relapse on tamoxifen.雌激素受体阳性、人表皮生长因子受体2阴性乳腺癌的淋巴结转移灶中孕激素受体表达缺失与他莫昔芬治疗后复发相关。
J Clin Pathol. 2017 Nov;70(11):954-960. doi: 10.1136/jclinpath-2016-204304. Epub 2017 Apr 17.
5
Are triple-negative tumours and basal-like breast cancer synonymous?三阴性肿瘤与基底样乳腺癌是同义词吗？
Breast Cancer Res. 2007;9(6):404; author reply 405. doi: 10.1186/bcr1827.
6
Potential therapeutic target for triple-negative breast cancer.三阴性乳腺癌的潜在治疗靶点。
Lancet Oncol. 2012 Aug;13(8):e330. doi: 10.1016/s1470-2045(12)70298-x.
7
Predictive parameters for internal mammary node drainage in patients with early breast cancer.早期乳腺癌患者内乳淋巴结引流的预测参数。
Tumori. 2014 May-Jun;100(3):254-8. doi: 10.1700/1578.17194.
8
Simple Prediction Model of Axillary Lymph Node Positivity After Analyzing Molecular and Clinical Factors in Early Breast Cancer.早期乳腺癌分子与临床因素分析后腋窝淋巴结阳性的简易预测模型
Medicine (Baltimore). 2016 May;95(20):e3689. doi: 10.1097/MD.0000000000003689.
9
Association between molecular subtypes and lymph node status in invasive breast cancer.浸润性乳腺癌分子亚型与淋巴结状态之间的关联
Int J Clin Exp Pathol. 2014 Sep 15;7(10):6800-6. eCollection 2014.
10
Use of ER/PR/HER2 subtypes in conjunction with the 2007 St Gallen Consensus Statement for early breast cancer.联合使用 ER/PR/HER2 亚型和 2007 年圣加仑共识声明进行早期乳腺癌治疗。
BMC Cancer. 2010 May 21;10:228. doi: 10.1186/1471-2407-10-228.

引用本文的文献

1
Collagen architecture in triple negative breast cancer.三阴性乳腺癌中的胶原蛋白结构
PLoS One. 2025 May 21;20(5):e0324655. doi: 10.1371/journal.pone.0324655. eCollection 2025.
2
The Relationship Between Mammographic Density and Factors Affecting Breast Cancer Risk.乳腺钼靶密度与影响乳腺癌风险因素之间的关系
Sisli Etfal Hastan Tip Bul. 2022 Mar 28;56(1):119-125. doi: 10.14744/SEMB.2021.30771. eCollection 2022.
3
A Provocative Molecular Link between Mammographic Density and BRCA1-loss associated TNBC.乳腺钼靶密度与BRCA1缺失相关三阴性乳腺癌之间的一个引发思考的分子联系。
Int J Hum Genet Genet Disord. 2019;1(1):1-8. doi: 10.18689/ijhg-1000101. Epub 2019 Jun 21.
4
Effect of Different Breast Densities and Average Glandular Dose on Contrast to Noise Ratios in Full-Field Digital Mammography: Simulation and Phantom Study.不同乳腺密度和平均腺体剂量对全视野数字乳腺摄影中对比度噪声比的影响：模拟与体模研究
Radiol Res Pract. 2018 Dec 10;2018:6192594. doi: 10.1155/2018/6192594. eCollection 2018.
5
Mammographic Breast Density and Breast Cancer Molecular Subtypes: The Kenyan-African Aspect.乳腺钼靶密度与乳腺癌分子亚型：肯尼亚-非洲视角。
Biomed Res Int. 2018 Jan 22;2018:6026315. doi: 10.1155/2018/6026315. eCollection 2018.
6
Breast Density Awareness and Knowledge, and Intentions for Breast Cancer Screening in a Diverse Sample of Women Age Eligible for Mammography.乳腺密度意识与知识，以及符合乳房X光检查年龄的不同女性样本中乳腺癌筛查的意向
J Cancer Educ. 2019 Feb;34(1):90-97. doi: 10.1007/s13187-017-1271-y.
7
Mammographic density, MRI background parenchymal enhancement and breast cancer risk.乳腺密度、MRI 背景实质增强与乳腺癌风险。
Ann Oncol. 2013 Nov;24 Suppl 8(Suppl 8):viii37-viii41. doi: 10.1093/annonc/mdt310.
8
Biological characteristics of interval cancers: a role for biomarkers in the breast cancer screening.间期癌的生物学特征：生物标志物在乳腺癌筛查中的作用。
J Cancer Res Clin Oncol. 2013 Feb;139(2):181-5. doi: 10.1007/s00432-012-1304-1. Epub 2012 Sep 9.
9
Breast cancer screening: the questions answered.乳腺癌筛查：问题解答。
Nat Rev Clin Oncol. 2012 Oct;9(10):599-605. doi: 10.1038/nrclinonc.2012.126. Epub 2012 Aug 14.

本文引用的文献

1
Mammographic breast density and subsequent risk of breast cancer in postmenopausal women according to tumor characteristics.根据肿瘤特征，绝经后妇女的乳腺 X 线摄影密度与乳腺癌后续风险。
J Natl Cancer Inst. 2011 Aug 3;103(15):1179-89. doi: 10.1093/jnci/djr225. Epub 2011 Jul 27.
2
Sex hormone levels and risks of estrogen receptor-negative and estrogen receptor-positive breast cancers.性激素水平与雌激素受体阴性和雌激素受体阳性乳腺癌的风险。
J Natl Cancer Inst. 2011 Apr 6;103(7):562-70. doi: 10.1093/jnci/djr031. Epub 2011 Feb 17.
3
Mammographic density and hormone receptor expression in breast cancer: the Multiethnic Cohort Study.乳腺癌的乳腺密度和激素受体表达：多民族队列研究。
Cancer Epidemiol. 2011 Oct;35(5):448-52. doi: 10.1016/j.canep.2010.11.011. Epub 2011 Jan 17.
4
Associations of breast cancer risk factors with tumor subtypes: a pooled analysis from the Breast Cancer Association Consortium studies.乳腺癌风险因素与肿瘤亚型的相关性：来自乳腺癌协会联盟研究的合并分析。
J Natl Cancer Inst. 2011 Feb 2;103(3):250-63. doi: 10.1093/jnci/djq526. Epub 2010 Dec 29.
5
Breast cancer risk by breast density, menopause, and postmenopausal hormone therapy use.按乳腺密度、绝经和绝经后激素治疗使用情况划分的乳腺癌风险。
J Clin Oncol. 2010 Aug 20;28(24):3830-7. doi: 10.1200/JCO.2009.26.4770. Epub 2010 Jul 19.
6
Mammographic density, estrogen receptor status and other breast cancer tumor characteristics.乳腺密度、雌激素受体状态和其他乳腺癌肿瘤特征。
Breast J. 2010 May-Jun;16(3):279-89. doi: 10.1111/j.1524-4741.2010.00907.x. Epub 2010 Feb 23.
7
Use of four biomarkers to evaluate the risk of breast cancer subtypes in the women's contraceptive and reproductive experiences study.使用四种生物标志物评估女性避孕和生殖经历研究中乳腺癌亚型的风险。
Cancer Res. 2010 Jan 15;70(2):575-87. doi: 10.1158/0008-5472.CAN-09-3460. Epub 2010 Jan 12.
8
Breast cancer receptor status: do results from a centralized pathology laboratory agree with SEER registry reports?乳腺癌受体状态：来自中央病理实验室的结果与监测、流行病学和最终结果（SEER）登记报告是否一致？
Cancer Epidemiol Biomarkers Prev. 2009 Aug;18(8):2214-20. doi: 10.1158/1055-9965.EPI-09-0301.
9
Does breast density show difference in patients with estrogen receptor-positive and estrogen receptor-negative breast cancer measured on MRI?在MRI上测量时，雌激素受体阳性和雌激素受体阴性乳腺癌患者的乳腺密度是否存在差异？
Ann Oncol. 2009 Aug;20(8):1447-9. doi: 10.1093/annonc/mdp362.
10
Underlying causes of the black-white racial disparity in breast cancer mortality: a population-based analysis.乳腺癌死亡率中黑人和白人种族差异的潜在原因：一项基于人群的分析。
J Natl Cancer Inst. 2009 Jul 15;101(14):993-1000. doi: 10.1093/jnci/djp176. Epub 2009 Jul 7.